Tuesday, December 3

Healthcare

Weight loss drug developers slump as Eli Lilly slashes cost of some Zepbound doses

08/28/20241 Min Read

cost developers doses drug Eli Lilly loss slashes slump weight Zepbound

Previous ArticleGSK stock climbs on Delaware court ruling in Zantac case

Next Article Centene is said to be ending broker commissions for Medicare Part D